Insider Transactions in Q4 2025 at Kiniksa Pharmaceuticals, Ltd. (KNSA)
Insider Transaction List (Q4 2025)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Dec 15
2025
|
Eben Tessari CHIEF OPERATING OFFICER |
SELL
Open market or private sale
|
Direct |
12,048
-41.96%
|
$493,968
$41.56 P/Share
|
|
Dec 15
2025
|
Eben Tessari CHIEF OPERATING OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct |
6,000
+17.28%
|
$48,000
$8.83 P/Share
|
|
Dec 15
2025
|
Barry D Quart |
SELL
Open market or private sale
|
Direct |
20,129
-61.6%
|
$825,289
$41.51 P/Share
|
|
Dec 15
2025
|
Barry D Quart |
BUY
Exercise of conversion of derivative security
|
Direct |
20,129
+38.12%
|
$201,290
$10.36 P/Share
|
|
Dec 08
2025
|
Mark Ragosa CHIEF FINANCIAL OFFICER |
SELL
Open market or private sale
|
Direct |
42,841
-57.95%
|
$1,756,481
$41.49 P/Share
|
|
Dec 08
2025
|
Mark Ragosa CHIEF FINANCIAL OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct |
42,841
+19.42%
|
$471,251
$11.28 P/Share
|
|
Nov 26
2025
|
Eben Tessari CHIEF OPERATING OFFICER |
SELL
Open market or private sale
|
Direct |
200
-0.87%
|
$8,400
$42.89 P/Share
|
|
Nov 26
2025
|
Eben Tessari CHIEF OPERATING OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct |
200
+0.87%
|
$4,400
$22.89 P/Share
|
|
Nov 17
2025
|
Eben Tessari CHIEF OPERATING OFFICER |
SELL
Open market or private sale
|
Direct |
12,470
-18.03%
|
$498,800
$40.69 P/Share
|
|
Nov 17
2025
|
Eben Tessari CHIEF OPERATING OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct |
6,500
+15.59%
|
$52,000
$8.83 P/Share
|
|
Nov 13
2025
|
Sanj K Patel CHAIRMAN & CEO |
BUY
Bona fide gift
|
Indirect |
60,000
+50.0%
|
-
|
|
Nov 13
2025
|
Sanj K Patel CHAIRMAN & CEO |
SELL
Bona fide gift
|
Indirect |
60,000
-53.67%
|
-
|
|
Nov 12
2025
|
Mark Ragosa CHIEF FINANCIAL OFFICER |
SELL
Open market or private sale
|
Direct |
19,900
-39.03%
|
$796,000
$40.94 P/Share
|
|
Nov 12
2025
|
Mark Ragosa CHIEF FINANCIAL OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct |
19,900
+28.07%
|
$597,000
$30.93 P/Share
|
|
Nov 12
2025
|
Sanj K Patel CHAIRMAN & CEO |
BUY
Bona fide gift
|
Indirect |
111,794
+50.0%
|
-
|
|
Nov 12
2025
|
Sanj K Patel CHAIRMAN & CEO |
SELL
Bona fide gift
|
Direct |
111,794
-100.0%
|
-
|
|
Oct 31
2025
|
John F. Paolini CHIEF MEDICAL OFFICER |
SELL
Open market or private sale
|
Direct |
82,542
-57.37%
|
$3,054,054
$37.14 P/Share
|
|
Oct 31
2025
|
John F. Paolini CHIEF MEDICAL OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct |
82,542
+25.71%
|
$495,252
$6.32 P/Share
|
|
Oct 28
2025
|
Mark Ragosa CHIEF FINANCIAL OFFICER |
SELL
Open market or private sale
|
Direct |
100
-0.32%
|
$4,100
$41.0 P/Share
|
|
Oct 28
2025
|
Mark Ragosa CHIEF FINANCIAL OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct |
100
+0.32%
|
$3,000
$30.93 P/Share
|
|
Oct 22
2025
|
Sanj K Patel CHAIRMAN & CEO |
SELL
Open market or private sale
|
Direct |
97,390
-46.56%
|
$3,700,820
$38.83 P/Share
|
|
Oct 22
2025
|
Sanj K Patel CHAIRMAN & CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
97,390
+31.77%
|
$292,170
$3.8 P/Share
|
|
Oct 21
2025
|
Sanj K Patel CHAIRMAN & CEO |
SELL
Open market or private sale
|
Direct |
39,331
-26.03%
|
$1,494,578
$38.77 P/Share
|
|
Oct 21
2025
|
Sanj K Patel CHAIRMAN & CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
39,331
+20.65%
|
$117,993
$3.8 P/Share
|
|
Oct 20
2025
|
Michael R Megna CHIEF ACCOUNTING OFFICER |
SELL
Open market or private sale
|
Direct |
50,490
-40.45%
|
$1,969,110
$39.02 P/Share
|
|
Oct 20
2025
|
Michael R Megna CHIEF ACCOUNTING OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct |
39,435
+11.32%
|
$473,220
$12.46 P/Share
|
|
Oct 20
2025
|
Sanj K Patel CHAIRMAN & CEO |
SELL
Open market or private sale
|
Direct |
121,248
-29.55%
|
$4,728,672
$39.07 P/Share
|
|
Oct 20
2025
|
Sanj K Patel CHAIRMAN & CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
121,248
+34.22%
|
$363,744
$3.8 P/Share
|
|
Oct 14
2025
|
Eben Tessari CHIEF OPERATING OFFICER |
SELL
Open market or private sale
|
Direct |
12,368
-15.34%
|
$457,616
$37.82 P/Share
|
|
Oct 14
2025
|
Eben Tessari CHIEF OPERATING OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct |
6,500
+13.67%
|
$52,000
$8.83 P/Share
|
|
Oct 04
2025
|
Michael R Megna CHIEF ACCOUNTING OFFICER |
SELL
Payment of exercise price or tax liability
|
Direct |
85
-0.22%
|
$3,230
$38.49 P/Share
|
|
Oct 04
2025
|
Michael R Megna CHIEF ACCOUNTING OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct |
175
+0.46%
|
-
|